ARCHIVES

FDA Approves Kytril For Post-Operative Nausea

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

FDA Expands Nexavar Indication To Include Thyroid Cancer

December 27, 2013

ACS Unveils Plan For Combating Tobacco Marketing

May 18, 1990

Clinical Trials Approved By NCI

March 26, 2004

IMRT Usage and Cost Related to Geography And Medicare Reimbursement Policy, Study Finds

April 29, 2011

President’s Budget Takes Care If R01s, P01s, Fattens Up NTP, Devastates Construction Grants

February 1, 1980